Oscar Health, Inc. (OSCR) Analyst/Investor Day September 16, 2026 9:00 AM EDT
Company Participants
Chris Potochar – Vice President of Treasury & Investor Relations
Mark Bertolini – CEO & Director
Richard Blackley – Chief Financial Officer
Janet Liang – EVP & President of Oscar Insurance
Mario Schlosser – Co-Founder, Advisor to the CEO & Director
Conference Call Participants
Andrew Mok – Barclays Bank PLC, Research Division
Stephen Baxter – Wells Fargo Securities, LLC, Research Division
Hua Ha – Robert W. Baird & Co. Incorporated, Research Division
Kevin Fischbeck – BofA Securities, Research Division
Sarah Conrad – Goldman Sachs Group, Inc., Research Division
Jessica Tassan – Piper Sandler & Co., Research Division
Jonathan Yong – UBS Investment Bank, Research Division
David Windley – Jefferies LLC, Research Division
Lance Wilkes – Bernstein Institutional Services LLC, Research Division
Presentation
Operator
Welcome to Oscar Health’s 2026 Investor Day. Please welcome Chris Potochar, Treasurer and Head of Investor Relations to the stage.
Chris Potochar
Vice President of Treasury & Investor Relations
Good morning. Welcome to Oscar Health’s 2026 Investor Day. It is great to see so many of you. I know it’s conference season. So thank you for joining us this morning. We appreciate you taking the time. I’d also like to welcome everyone that’s joining from the webcast this morning as well. Thank you for joining. For your reference, all the materials that we will present today will be available a little bit later this morning, and you can find that on our Investor Relations website at ir.oscarhealth.com.
As a reminder, any remarks Oscar makes about the future constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by those forward-looking statements as a result of various important factors, including those discussed in our most recent annual report on
